Strides gets USD20mn to grow its OTC business

5 November 2018 - Deborah Wilkes


Strides Pharma Science is set to receive private-equity funding worth USD20 million to grow its Consumer Healthcare business.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: